MXCT vs TXN · rev $38.6M vs P/E 52, rev $17.68B
MaxCyte Inc (MXCT) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
MXCT currently screens at market cap $124.3M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the MXCT and TXN stock pages for the full models.
Not investment advice.